Further studies in parenteral nutrition.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to L Heller.
Explore the source record for details and available documents.
Four groups of six volunteers were given continuous infusions of glucose, fructose, sorbitol and xylitol in a dosage of 0.25 g/kg body weight over 48 hours. All solutions were well tolerated provided that potassium was supplemented in sufficient amounts. During the first 12 hour period of xylitol infusion renal potassium loss was greater than during infusion of all other substrates. No substantial differences in the alterations of the other parameters were noted between glucose and glucose substitutes. The only exception was the rise in serum uric acid concentration during infusion of xylitol and of fructose, which was not noted during infusion of glucose or sorbitol. The concentration of serum bilirubin was elevated during infusion of all four substances. The decrease in serum free fatty acid concentration was equally caused by glucose, fructose, xylitol or sorbitol. The increase in serum triglyceride concentration was observed earlier during the infusion of glucose substitutes as compared to glucose. Blood glucose concentration was only elevated during infusion of glucose. In the post infusion period there was quick rise in fatty acid concentration after cessation of glucose infusion. This normalisation occurred more slowly after stopping fructose and particulary xylitol or sorbitol. These results have no indications for adverse effects of the continuous infusions of glucose or glucose substitutes.
Explore the source record for details and available documents.
Postoperative parenteral nutrition can only be optimally effective if the characteristics of post-traumatic metabolism are taken into account. Two main possibilities are discussed for the carbohydrate component of parenteral nutrition during this phase: glucose with high doses of insulin or non-glucose carbohydrates (sugar substitutes) possibly in a suitable combination with glucose. The risks as well as the technical and organisational problems involved in the use of them are discussed and the authors prefer the second of the two alternatives. Possible side effects of non-glucose carbohydrates are pointed out and it is shown how these can be avoided by observing dose guidelines. So far a combination of frucose : glucose : xylitol in a ratio of 2 : 1 :1 with a total dose of 0.50 g/kg/hour has been studied most thoroughly. This combination normalises the fat metabolism and improves glucose tolerance without requiring exogenous insulin. Experiences with this combination as well as individual non-glucose carbohydrates on operated patients have been given continuously for up to 7 days and in some cases even for several weeks. No side effects, no deviations from a steady state and no abnormal changes of the laboratory values occurred. The authors are of the opinion that non glucose carbohydrates are necessary if the facilities for frequent blood sugar controls are not available.
The metabolic effects of intravenous infusion of glucose, fructose, sorbitol or xylitol were investigated using human volunteers. The infusion period was 4 hours or 48 hours. Serum phosphate concentration decreased quickly and independent on the kind of the carbohydrate used. On the other hand, the serum concentration of potassium or sodium did not show any greater deviations from normal. Considering the renal excretion, greater differences between the single substances were seen. Renal potassium excretion was increased especially during xylitol infusions, and not as much during sorbitol infusions, as compared to infusions with glucose or with fructose. These differences were demonstrated especially for the first 12 hours of the infusions periond. During the infusions of glucose or of fructose an oral substitution of the electrolytes was suggicient. However, during xylitol infusions an intravenous substitution of potassium salts was necessary, despite the fact that the changes in serum concentration were only small. It is emphasized to carefully monitor serum electrolyte concentration and renal electrolyte excretion during long lasting intravenous infusions therapy.
Many of the fair and poor results are directly traceable to errors in technique. Patient selection is also important. The operation can be done in adolescents since there is no growth plate at the distal end of the first metatarsal. We do not currently recommend this procedure for those over 60, for those with first metatarsophalangeal osteoarthritis or hallux rigidus or for those with moderate or severe rheumatoid arthritis. For these patients we usually do a Keller excisional arthroplasty. Our use of the osteotomy-bunionectomy operation for the patient with hallux valgus with an associated metatarsalgia or short first metatarsal has now become more cautious. We feel that the operation is not indicated for those with significant preoperative metatarsalgia, especially if the first metatarsal is shorter than the second, or for those whose first metatarsal is more than 4 or 5 millimeters shorter than the second, regardless of preoperative metatarsalgia. In these patients a McBride procedure or a proximal opening-wedge osteotomy is done.
In groups of volunteers the concentration differences of phosphate potassium and sodium in serum were measured during 48-hour continuous infusion of glucose or glucose substitutes (fructose, sorbitol or xylitol). The dosage was 0.25 g/kg BW/hour. Additionally, the effect of fructose infusion in a dosage of 0.5 g/kg BW/hour was observed. Besides, the urinary excretion of sodium and of potassium was analysed. In contrast to short-term and high-dosed infusions of glucose or glucose substitutes, the phosphate concentration in serum was scarcely influenced. Only during high-dosed fructose infusion and during infusion of xylitol and sorbitol a small decrease in serum phosphate concentration was noticed. The effect of xylitol is pronounced. Additionally, the sodium concentration in serum was especially decreased during xylitol infusion. With regard to the sodium excretion - and less pronounced with regard to the potassium excretion - a gradual adaptation to the infusion of the electrolyte-free solution is observed. The excretion of the cations is more and more decreased. In particular the excretion of sodium and of potassium is very high in the initial period, i.e. in the course of the first twelve hours of the xylitol infusions. On the other hand, the potassium excretion is very low in the final period of the infusion of xylitol (during 36 hours up to 48 hours) in comparison to the other sugars.
Amino acids, intraamnially administered, disappear unexpectedly rapidly and relatively uniformly from the amniotic fluid. During a placental insufficiency and thus a simultaneously present intrauterine protein deficiency, the amino acid level in the amniotic fluid decreases especially rapidly whereas it remains practically unchanged for hours following death in utero. This observation suggests that the infused amino acids are utilized by the living fetus. This is supported by a decrease in the glucose concentration and an increase in the pyruvate of the amniotic fluid. According to the experiences obtained until now it seems reasonable to supply the fetus with vital substrates via the paraplacental route.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.